Overactivation of the androgen receptor exacerbates gravid uterine ferroptosis via interaction with and suppression of the NRF2 defense signaling pathway
暂无分享,去创建一个
M. Brännström | Min Hu | Yuehui Zhang | Linus R. Shao | H. Billig | Yu Zhou | Lingjing Lu | Denghui Wu
[1] R. Menon,et al. The role of nuclear factor erythroid 2–related factor 2 (NRF2) in normal and pathological pregnancy: A systematic review , 2021, American journal of reproductive immunology.
[2] S. Palomba. Is fertility reduced in ovulatory women with polycystic ovary syndrome? An opinion paper. , 2021, Human reproduction.
[3] D. Tang,et al. Signaling pathways and defense mechanisms of ferroptosis , 2021, The FEBS journal.
[4] M. Brännström,et al. Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance , 2021, Journal of Molecular Medicine.
[5] T. Morgan,et al. Age-related alteration in HNE elimination enzymes. , 2021, Archives of biochemistry and biophysics.
[6] A. Gomes,et al. Western Blotting Using In-Gel Protein Labeling as a Normalization Control: Advantages of Stain-Free Technology. , 2021, Methods in molecular biology.
[7] M. Brännström,et al. TLR4-associated IRF-7 and NFĸB signaling acts as a molecular link between androgen and metformin activities and cytokine synthesis in the PCOS endometrium. , 2020, The Journal of clinical endocrinology and metabolism.
[8] L. Giudice,et al. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. , 2020, Human reproduction update.
[9] T. Piltonen,et al. Update on PCOS: Consequences, Challenges and Guiding Treatment. , 2020, The Journal of clinical endocrinology and metabolism.
[10] D. Tang,et al. Iron Metabolism in Ferroptosis , 2020, Frontiers in Cell and Developmental Biology.
[11] H. Preissl,et al. Pregnancy outcome in women with polycystic ovary syndrome in relation to second-trimester testosterone levels. , 2020, Reproductive biomedicine online.
[12] D. Klionsky,et al. Ferroptosis: machinery and regulation , 2020, Autophagy.
[13] Ulrich Dirnagl,et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research* , 2020, BMC Veterinary Research.
[14] B. Wang,et al. Hyperandrogenism and insulin resistance modulate gravid uterine and placental ferroptosis in PCOS-like rats. , 2020, The Journal of endocrinology.
[15] D. Tang,et al. Transcription factors in ferroptotic cell death , 2020, Cancer Gene Therapy.
[16] J. Brosens,et al. The proliferative phase endometrium in IVF/ICSI: an in-cycle molecular analysis predictive of the outcome following fresh embryo transfer. , 2020, Human reproduction.
[17] Y. Keum,et al. Binding partners of NRF2: Functions and regulatory mechanisms. , 2019, Archives of biochemistry and biophysics.
[18] M. Bertoldo,et al. The Mechanism of Androgen Actions in PCOS Etiology , 2019, Medical sciences.
[19] Wei Li,et al. Hyperandrogenism and insulin resistance‐induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome , 2019, The Journal of physiology.
[20] P. Vandenabeele,et al. The molecular machinery of regulated cell death , 2019, Cell Research.
[21] J. Levine,et al. Hyperandrogenic origins of polycystic ovary syndrome – implications for pathophysiology and therapy , 2019, Expert review of endocrinology & metabolism.
[22] M. Olfert,et al. Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity , 2018, International journal of environmental research and public health.
[23] Seema Patel. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy , 2018, The Journal of Steroid Biochemistry and Molecular Biology.
[24] I. Brandslund,et al. Testosterone Levels in Third Trimester in Polycystic Ovary Syndrome: Odense Child Cohort , 2018, The Journal of clinical endocrinology and metabolism.
[25] M. Brännström,et al. Uterine progesterone signaling is a target for metformin therapy in PCOS-like rats. , 2018, The Journal of endocrinology.
[26] R. Campbell,et al. Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS. , 2018, JCI insight.
[27] J. Jansson,et al. Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver , 2018, Oncotarget.
[28] D. Modi,et al. Embryo Implantation: War in Times of Love. , 2018, Endocrinology.
[29] D. Tuveson,et al. Transcriptional Regulation by Nrf2 , 2017, Antioxidants & redox signaling.
[30] D. Gibson,et al. Androgens and endometrium: New insights and new targets , 2017, Molecular and Cellular Endocrinology.
[31] Tobias Jung,et al. 4‐Hydroxynonenal (HNE) modified proteins in metabolic diseases , 2017, Free radical biology & medicine.
[32] Hiroki Shima,et al. Glucocorticoid receptor signaling represses the antioxidant response by inhibiting histone acetylation mediated by the transcriptional activator NRF2 , 2017, The Journal of Biological Chemistry.
[33] T. Piltonen. Polycystic ovary syndrome: Endometrial markers. , 2016, Best practice & research. Clinical obstetrics & gynaecology.
[34] C. Gargett,et al. Fertile ground: human endometrial programming and lessons in health and disease , 2016, Nature Reviews Endocrinology.
[35] Wei Li,et al. Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus , 2016, Scientific Reports.
[36] M. Fleming,et al. The placenta: the forgotten essential organ of iron transport. , 2016, Nutrition reviews.
[37] D. Gibson,et al. Regulation of androgen action during establishment of pregnancy. , 2016, Journal of molecular endocrinology.
[38] H. Teede,et al. Polycystic ovary syndrome , 2016, Nature Reviews Disease Primers.
[39] Min Hu,et al. Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome , 2015, International journal of biological sciences.
[40] G. Mann,et al. Keap1-Nrf2 regulated redox signaling in utero: Priming of disease susceptibility in offspring. , 2015, Free radical biology & medicine.
[41] Qitao Ran,et al. Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis* , 2015, The Journal of Biological Chemistry.
[42] A. Walch,et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice , 2014, Nature Cell Biology.
[43] H. Aburatani,et al. Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer. , 2014, Molecular endocrinology.
[44] F. Deeba,et al. Association of infertile patients having polycystic ovarian syndrome with recurrent miscarriage. , 2014, Mymensingh medical journal : MMJ.
[45] Akhileshwar Namani,et al. Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer. , 2014, Biochimica et biophysica acta.
[46] Suzanne M. McCahan,et al. Transcriptome Analysis of the Dihydrotestosterone-Exposed Fetal Rat Gubernaculum Identifies Common Androgen and Insulin-Like 3 Targets1 , 2013, Biology of reproduction.
[47] M. Murri,et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. , 2013, Human reproduction update.
[48] Takahiro Matsumoto,et al. The androgen receptor in health and disease. , 2013, Annual review of physiology.
[49] T. Sir-Petermann,et al. Placental steroidogenesis in pregnant women with polycystic ovary syndrome. , 2013, European journal of obstetrics, gynecology, and reproductive biology.
[50] R. Brigelius-Flohé,et al. Glutathione peroxidases. , 2013, Biochimica et biophysica acta.
[51] J. Brosens,et al. Disordered IL-33/ST2 Activation in Decidualizing Stromal Cells Prolongs Uterine Receptivity in Women with Recurrent Pregnancy Loss , 2012, PloS one.
[52] A. Baniahmad,et al. Androgen receptor-mediated gene repression , 2012, Molecular and Cellular Endocrinology.
[53] Donna D. Zhang,et al. Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. , 2009, Molecular cell.
[54] B. Fauser,et al. Pregnancy complications in women with polycystic ovary syndrome. , 2008, Seminars in reproductive medicine.
[55] C. Ling,et al. Developmental and hormonal regulation of progesterone receptor A-form expression in female mouse lung in vivo: interaction with glucocorticoid receptors. , 2006, The Journal of endocrinology.
[56] Masayuki Yamamoto,et al. Nrf2-Keap1 defines a physiologically important stress response mechanism. , 2004, Trends in molecular medicine.
[57] M. Ferin,et al. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. , 2003, The Journal of clinical endocrinology and metabolism.
[58] M. Fassnacht,et al. Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome. , 2003, The Journal of clinical endocrinology and metabolism.
[59] M. Maliqueo,et al. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. , 2002, Human reproduction.
[60] I. Kakizaki,et al. Activation of mouse Pi-class glutathione S-transferase gene by Nrf2(NF-E2-related factor 2) and androgen. , 2002, The Biochemical journal.
[61] M. Tsai,et al. Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter. , 1999, Molecular endocrinology.
[62] T. Li,et al. Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. , 1998, Fertility and sterility.
[63] C. Labrie,et al. Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity. , 1997, Urology.
[64] M. Mattei,et al. Structural organization and regulation of the gene for the androgen-dependent glutathione peroxidase-like protein specific to the mouse epididymis. , 1993, Molecular endocrinology.
[65] P. Poyet,et al. Comparison of the antiandrogenic/androgenic activities of flutamide, cyproterone acetate and megestrol acetate , 1985, Molecular and Cellular Endocrinology.